$0.2000
-0.01-6.80%
Pre-Market: 7:16 AM EDT
Comments
Loading...
X4 Pharmaceuticals Insider Trading Activity | NASDAQ:XFOR | Benzinga
Track the latest X4 Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for X4 Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are X4 Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 14, 2025, Mark Baldry, the company's CHIEF COMMERCIAL OFFICER purchased 635.05K shares for $0.55 each.
Ownership Statistics for X4 Pharmaceuticals Inc
Shares Outstanding
173.662M
Insider Shares Owned
9.449M
Insider Percentage Owned
5.44%
Institutional Shares Held
33.732M
Institutional Percentage Held
19.4%
| Feb 14, 2025 | Mark Baldry | CHIEF COMMERCIAL OFFICER | 635.05K | $0.55 | $19.25K | BUY | 674.70% | 729.17K | May 17 - Feb 12 | View |
| Jan 27, 2025 | Paula Ragan | PRESIDENT AND CEO | 93.47K | $0.45 | -$34.72K | GRANT | 9.40% | 1.09M | Jan 23 - Jan 24 | View |
| Jan 27, 2025 | Adam Mostafa | CHIEF FINANCIAL OFFICER | 0.00 | $0.45 | -$33.95K | GRANT | 0.00% | 0.00 | Jan 23 - Jan 24 | View |
| Jan 27, 2025 | Mark Baldry | CHIEF COMMERCIAL OFFICER | 45.61K | $0.45 | -$13.24K | GRANT | 94.03% | 94.12K | Jan 23 - Jan 24 | View |
| Jan 27, 2025 | Mary DiBiase | CHIEF OPERATING OFFICER | 38.92K | $0.45 | -$10.09K | GRANT | 8.61% | 490.98K | Jan 23 - Jan 24 | View |
| Jan 27, 2025 | Christophe ArbetEngels | CHIEF MEDICAL OFFICER | 14.21K | $0.45 | -$5.28K | GRANT | ∞ | 14.21K | Jan 23 - Jan 24 | View |
| Nov 19, 2024 | Paula Ragan | PRESIDENT AND CEO | -31.90K | $0.39 | -$12.58K | SELL | -3.11% | 993.92K | Nov 15 | View |
| Oct 16, 2024 | Paula Ragan | PRESIDENT AND CEO | -31.90K | $0.56 | -$17.93K | SELL | -3.02% | 1.03M | Oct 15 | View |
| Oct 08, 2024 | Adam Mostafa | CHIEF FINANCIAL OFFICER | 0.00 | $0.55 | -$126.90K | GRANT | 0.00% | 0.00 | Oct 04 - Oct 07 | View |
| Oct 08, 2024 | Mark Baldry | CHIEF COMMERCIAL OFFICER | 23.82K | $0.58 | -$6.51K | GRANT | 96.47% | 48.51K | Oct 04 - Oct 07 | View |
| Oct 08, 2024 | Paula Ragan | PRESIDENT AND CEO | 292.64K | $0.55 | -$131.52K | GRANT | 38.25% | 1.06M | Oct 04 - Oct 07 | View |
| Oct 08, 2024 | Mary DiBiase | CHIEF OPERATING OFFICER | 162.95K | $0.57 | -$38.33K | GRANT | 56.36% | 452.06K | Oct 04 - Oct 07 | View |
| Oct 08, 2024 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | 153.72K | $0.56 | -$43.31K | GRANT | 65.61% | 388.03K | Oct 04 - Oct 07 | View |
| Sep 11, 2024 | Mary DiBiase | CHIEF OPERATING OFFICER | -2.64K | $0.66 | -$1.74K | SELL | -0.91% | 289.11K | Sep 09 | View |
| Mar 11, 2024 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -14.23K | $0.88 | -$12.55K | SELL | -5.73% | 234.30K | Mar 11 | View |
| Mar 11, 2024 | Paula Ragan | PRESIDENT AND CEO | -49.68K | $0.88 | -$43.86K | SELL | -6.10% | 765.07K | Mar 11 | View |
| Mar 11, 2024 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -52.50K | $0.88 | -$46.35K | SELL | -100.00% | 0.00 | Mar 11 | View |
| Mar 11, 2024 | Mary DiBiase | CHIEF OPERATING OFFICER | -15.41K | $0.88 | -$13.59K | SELL | -5.02% | 291.75K | Mar 11 | View |
| Feb 12, 2024 | Mary DiBiase | CHIEF OPERATING OFFICER | -3.68K | $1.01 | -$3.71K | SELL | -1.18% | 307.16K | Feb 12 | View |
| Feb 12, 2024 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -787.00 | $1.01 | -$792.67 | SELL | -0.32% | 248.54K | Feb 12 | View |
| Feb 12, 2024 | Paula Ragan | PRESIDENT AND CEO | -21.70K | $1.01 | -$21.89K | SELL | -2.59% | 814.75K | Feb 12 | View |
| Feb 12, 2024 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -27.72K | $1.01 | -$27.97K | SELL | -34.56% | 52.50K | Feb 12 | View |
| Nov 03, 2023 | Paula Ragan | PRESIDENT AND CEO | -239.44K | $0.76 | -$181.57K | SELL | -22.26% | 836.44K | Nov 01 - Nov 03 | View |
| Nov 03, 2023 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -230.65K | $0.73 | -$168.37K | SELL | -74.19% | 80.22K | Nov 01 | View |
| Nov 03, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -67.69K | $0.73 | -$49.42K | SELL | -17.88% | 310.84K | Nov 01 | View |
| Nov 03, 2023 | Mark Baldry | CHIEF COMMERCIAL OFFICER | -10.26K | $0.73 | -$7.49K | SELL | -29.35% | 24.69K | Nov 01 | View |
| Nov 03, 2023 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -67.69K | $0.73 | -$49.42K | SELL | -21.35% | 249.32K | Nov 01 | View |
| Sep 12, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -2.64K | $1.25 | -$3.30K | SELL | -1.76% | 147.89K | Sep 08 | View |
| Aug 22, 2023 | MICHAEL WYZGA | DIRECTOR | 25.00K | $1.20 | $29.88K | BUY | 48.39% | 76.67K | Aug 18 | View |
| Aug 11, 2023 | Murray Stewart | INTERIM CHIEF MEDICAL OFFICER | 139.84K | $1.06 | -$137.86K | GRANT | 2097.45% | 146.50K | Aug 09 - Aug 10 | View |
| Jul 05, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -464.00 | $1.89 | -$876.96 | SELL | -0.31% | 150.54K | Jun 30 | View |
| Jul 05, 2023 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -2.64K | $1.89 | -$4.99K | SELL | -3.19% | 80.22K | Jun 30 | View |
| Jun 26, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -857.00 | $1.93 | -$1.65K | SELL | -0.56% | 151.00K | Jun 23 | View |
| Jun 26, 2023 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -5.42K | $1.93 | -$10.45K | SELL | -6.14% | 82.86K | Jun 23 | View |
| Jun 26, 2023 | Paula Ragan | PRESIDENT AND CEO | -6.72K | $1.92 | -$12.91K | SELL | -1.22% | 543.80K | Jun 23 | View |
| Jun 16, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -857.00 | $2.23 | -$1.91K | SELL | -0.56% | 151.86K | Jun 15 | View |
| Jun 16, 2023 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -5.42K | $2.22 | -$12.03K | SELL | -5.78% | 88.28K | Jun 15 | View |
| Jun 16, 2023 | Paula Ragan | PRESIDENT AND CEO | -6.72K | $2.23 | -$14.99K | SELL | -1.21% | 550.52K | Jun 15 | View |
| May 31, 2023 | Paula Ragan | PRESIDENT AND CEO | -6.29K | $1.95 | -$12.27K | SELL | -1.12% | 557.25K | May 31 | View |
| Mar 13, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -18.19K | $0.84 | -$15.28K | SELL | -10.64% | 152.71K | Mar 10 | View |
| Mar 13, 2023 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -52.50K | $0.84 | -$44.10K | SELL | -35.91% | 93.70K | Mar 10 | View |
| Mar 13, 2023 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -16.81K | $0.84 | -$14.12K | SELL | -16.29% | 86.37K | Mar 10 | View |
| Mar 13, 2023 | Paula Ragan | PRESIDENT AND CEO | -49.68K | $0.84 | -$41.73K | SELL | -8.10% | 563.54K | Mar 10 | View |
| Feb 15, 2023 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -928.00 | $0.93 | -$863.04 | SELL | -0.89% | 103.18K | Feb 13 | View |
| Feb 15, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -4.35K | $0.93 | -$4.04K | SELL | -2.48% | 170.91K | Feb 13 | View |
| Feb 15, 2023 | Adam S Mostafa | CHIEF FINANCIAL OFFICER | -27.72K | $0.93 | -$25.78K | SELL | -15.94% | 146.20K | Feb 13 | View |
| Feb 15, 2023 | Paula Ragan | PRESIDENT AND CEO | -21.70K | $0.93 | -$20.18K | SELL | -3.42% | 613.22K | Feb 13 | View |
| Aug 19, 2022 | Derek M Meisner | CHIEF LEGAL OFFICER | -8.33K | $0.00 | $0.00 | SELL | -5.43% | 145.16K | Aug 17 | View |
| Aug 19, 2022 | Mary DiBiase | CHIEF OPERATING OFFICER | -1.71K | $0.00 | $0.00 | SELL | -0.95% | 177.90K | Aug 17 | View |
| Aug 19, 2022 | Paula Ragan | PRESIDENT AND CEO | -13.45K | $0.00 | $0.00 | SELL | -2.07% | 634.91K | Aug 17 | View |
| Aug 19, 2022 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -10.83K | $0.00 | $0.00 | SELL | -5.86% | 173.92K | Aug 17 | View |
| Jul 01, 2022 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -2.64K | $0.00 | $0.00 | SELL | -1.41% | 184.75K | Jun 30 | View |
| Jul 01, 2022 | Mary DiBiase | CHIEF OPERATING OFFICER | -1.58K | $0.00 | $0.00 | SELL | -0.87% | 179.61K | Jun 30 | View |
| Jun 27, 2022 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -5.42K | $0.00 | $0.00 | SELL | -2.81% | 187.39K | Jun 24 | View |
| Jun 27, 2022 | Mary DiBiase | CHIEF OPERATING OFFICER | -856.00 | $0.00 | $0.00 | SELL | -0.47% | 181.19K | Jun 24 | View |
| Jun 27, 2022 | Paula Ragan | PRESIDENT AND CEO | -6.72K | $0.00 | $0.00 | SELL | -1.03% | 648.36K | Jun 24 | View |
| Jun 27, 2022 | Derek M Meisner | CHIEF LEGAL OFFICER | -4.17K | $0.00 | $0.00 | SELL | -2.64% | 153.49K | Jun 24 | View |
| Jun 17, 2022 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -5.42K | $0.00 | $0.00 | SELL | -2.73% | 192.81K | Jun 16 | View |
| Jun 17, 2022 | Paula Ragan | PRESIDENT AND CEO | -6.72K | $0.00 | $0.00 | SELL | -1.02% | 655.08K | Jun 16 | View |
| Jun 17, 2022 | Mary DiBiase | CHIEF OPERATING OFFICER | -856.00 | $0.00 | $0.00 | SELL | -0.47% | 182.04K | Jun 16 | View |
| Jun 17, 2022 | Derek M Meisner | CHIEF LEGAL OFFICER | -4.17K | $0.00 | $0.00 | SELL | -2.57% | 157.66K | Jun 16 | View |
| Jun 06, 2022 | Paula Ragan | PRESIDENT AND CEO | -6.29K | $1.21 | -$7.61K | SELL | -0.94% | 661.81K | Jun 03 | View |
| Feb 14, 2022 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -27.72K | $0.00 | $0.00 | SELL | -22.92% | 93.22K | Feb 11 | View |
| Feb 14, 2022 | Derek M Meisner | CHIEF LEGAL OFFICER | -15.91K | $0.00 | $0.00 | SELL | -21.87% | 56.82K | Feb 11 | View |
| Feb 14, 2022 | Mary DiBiase | CHIEF OPERATING OFFICER | -12.54K | $0.00 | $0.00 | SELL | -13.87% | 77.90K | Feb 11 | View |
| Feb 14, 2022 | Paula Ragan | PRESIDENT AND CEO | -21.70K | $0.00 | $0.00 | SELL | -4.63% | 447.31K | Feb 11 | View |
| Feb 14, 2022 | Diego Cadavid | CHIEF MEDICAL OFFICER | -928.00 | $0.00 | $0.00 | SELL | -11.55% | 7.11K | Feb 11 | View |
| Aug 19, 2021 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -10.83K | $5.10 | -$55.24K | SELL | -8.22% | 120.94K | Aug 17 | View |
| Aug 19, 2021 | Derek M Meisner | GENERAL COUNSEL | -8.33K | $5.10 | -$42.49K | SELL | -10.28% | 72.73K | Aug 17 | View |
| Aug 19, 2021 | Paula Ragan | PRESIDENT AND CEO | -13.45K | $5.10 | -$68.58K | SELL | -2.79% | 469.00K | Aug 17 | View |
| Jul 16, 2021 | Paula Ragan | PRESIDENT AND CEO | -13.45K | $5.78 | -$77.73K | SELL | -2.71% | 482.45K | Jul 15 | View |
| Jul 01, 2021 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -2.64K | $6.64 | -$17.54K | SELL | -1.96% | 131.78K | Jun 30 | View |
| Jun 25, 2021 | Adam Mostafa | CHIEF FINANCIAL OFFICER | 10.83K | $7.01 | -$37.97K | GRANT | 8.77% | 134.42K | Jun 23 - Jun 24 | View |
| Jun 25, 2021 | Derek M Meisner | GENERAL COUNSEL | 8.33K | $7.00 | -$29.16K | GRANT | 11.46% | 81.06K | Jun 23 - Jun 24 | View |
| Jun 17, 2021 | Derek M Meisner | GENERAL COUNSEL | 8.33K | $7.84 | -$32.66K | GRANT | 12.94% | 72.73K | Jun 15 | View |
| Jun 17, 2021 | Adam Mostafa | CHIEF FINANCIAL OFFICER | 10.83K | $7.84 | -$42.47K | GRANT | 9.61% | 123.58K | Jun 15 | View |
| Jun 02, 2021 | Paula Ragan | PRESIDENT AND CEO | -2.40K | $9.50 | -$22.80K | SELL | -0.59% | 406.25K | Jun 02 | View |
| Jun 02, 2021 | Paula Ragan | PRESIDENT AND CEO | -4.10K | $9.41 | -$38.62K | SELL | -0.99% | 408.65K | Jun 01 | View |
| May 04, 2021 | Paula Ragan | PRESIDENT AND CEO | -2.40K | $8.33 | -$19.99K | SELL | -0.58% | 412.75K | May 03 | View |
| Apr 07, 2021 | Paula Ragan | PRESIDENT AND CEO | -2.40K | $9.17 | -$22.01K | SELL | -0.57% | 415.15K | Apr 05 | View |
| Mar 02, 2021 | Paula Ragan | PRESIDENT AND CEO | -2.40K | $9.74 | -$23.38K | SELL | -0.87% | 272.92K | Mar 02 | View |
| Feb 03, 2021 | Paula Ragan | PRESIDENT AND CEO | -2.40K | $7.88 | -$18.91K | SELL | -0.86% | 275.32K | Feb 02 | View |
| Jan 06, 2021 | Paula Ragan | PRESIDENT AND CEO | -2.40K | $7.00 | -$16.80K | SELL | -0.86% | 277.72K | Jan 05 | View |
| Dec 28, 2020 | Paula Ragan | — | -4.80K | $7.00 | -$33.60K | SELL | -1.68% | 280.12K | Dec 23 | View |
| Oct 06, 2020 | Paula Ragan | — | -1.80K | $7.00 | -$12.58K | SELL | -0.63% | 284.92K | Oct 05 | View |
| Oct 05, 2020 | Paula Ragan | — | -603.00 | $7.00 | -$4.22K | SELL | -0.21% | 286.72K | Oct 02 | View |
| Sep 22, 2020 | Adam Mostafa | — | -10.83K | $7.08 | -$76.70K | SELL | -26.80% | 29.59K | Sep 21 | View |
| Sep 10, 2020 | Renato Skerlj | — | -5.83K | $8.05 | -$46.96K | SELL | -12.18% | 42.08K | Sep 09 | View |
| Sep 10, 2020 | Paula Ragan | — | -8.84K | $8.04 | -$71.07K | SELL | -2.98% | 287.32K | Sep 09 | View |
| Sep 10, 2020 | Derek M Meisner | — | -8.33K | $8.05 | -$67.09K | SELL | -33.34% | 16.67K | Sep 09 | View |
| Sep 03, 2020 | Paula Ragan | — | -2.40K | $7.99 | -$19.18K | SELL | -0.80% | 296.16K | Sep 02 | View |
| Aug 04, 2020 | Paula Ragan | — | -2.40K | $7.45 | -$17.88K | SELL | -1.14% | 208.91K | Aug 03 | View |
| Jul 06, 2020 | Paula Ragan | — | -2.40K | $9.05 | -$21.72K | SELL | -1.12% | 211.31K | Jul 02 | View |
| Jul 01, 2020 | Adam Mostafa | — | -2.64K | $9.14 | -$24.13K | TAX | -25.00% | 7.92K | Jun 30 | View |
| Jun 03, 2020 | Paula Ragan | — | -16.38K | $8.78 | -$143.85K | SELL | -7.12% | 213.71K | Jun 01 - Jun 03 | View |
| May 05, 2020 | Paula Ragan | — | -2.40K | $8.92 | -$21.41K | SELL | -1.03% | 230.09K | May 04 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
XFOR Insider Trading News
No news found